Showing results (271-280 of 560) with videos related to
Sort By:
Pageof 56
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|August 8, 2014
[A case of chronic hepatitis B managed with continued adefovir despite treatment-related Fanconi syndrome and osteomalacia]Yasuhiro Iizuka, Hideki Sakai, Konomi Kobayashi, et al.Journal of Crohn'S & Colitis|June 14, 2014
A randomized clinical trial of mesalazine suppository: the usefulness and problems of central review of evaluations of colonic mucosal findingsKiyonori Kobayashi, Fumihito Hirai, Makoto Naganuma, et al.Inflammatory Bowel Diseases|January 9, 2007
Extracorporeal elimination of TNF-alpha-producing CD14(dull)CD16(+) monocytes in leukocytapheresis therapy for ulcerative colitisTakanori Kanai, Shin Makita, Takahiro Kawamura, et al.Journal of Gastroenterology|March 17, 2010
Inflammatory bowel disease in children: epidemiological analysis of the nationwide IBD registry in JapanTakashi Ishige, Takeshi Tomomasa, Tohru Takebayashi, et al.Therapeutic Advances in Gastrointestinal Endoscopy|June 16, 2022
Endoscopic mucosal resection using a ligation device for duodenal neuroendocrine tumors: a simple methodYasuhiro Inokuchi, Kei Hayashi, Yoshihiro Kaneta, et al.Clinical Case Reports|June 29, 2022
Successful resection of gastric cancer arising from a heterotopic gastric gland in the submucosa by endoscopic submucosal dissectionYasuhiro Inokuchi, Kota Washimi, Mamoru Watanabe, et al.Gastroenterology|September 2, 2015
Safety and Efficacy of AJM300, an Oral Antagonist of α4 Integrin, in Induction Therapy for Patients With Active Ulcerative ColitisNaoki Yoshimura, Mamoru Watanabe, Satoshi Motoya, et al.Journal of Gastroenterology|October 14, 2017
Correction to: Complete mucosal healing of distal lesions induced by twice-daily budesonide 2-mg foam promoted clinical remission of mild-to-moderate ulcerative colitis with distal active inflammation: double-blind, randomized studyMakoto Naganuma, Nobuo Aoyama, Tomohiro Tada, et al.Inflammatory Intestinal Diseases|June 30, 2020
Management of Primary Nonresponders and Partial Responders to Tumor Necrosis Factor-α Inhibitor Induction Therapy among Patients with Crohn's DiseaseHideki Iijima, Taku Kobayashi, Mitsuo Nagasaka, et al.The Journal of Infectious Diseases|March 20, 2004
Quantitation of the level of hepatitis delta virus RNA in serum, by real-time polymerase chain reaction--and its possible correlation with the clinical stage of liver diseaseTsuyoshi Yamashiro, Kazuyoshi Nagayama, Nobuyuki Enomoto, et al.Pageof 56